Cita APA

Newton, J., Palladino, E. N., Weigel, C., Maceyka, M., Gräler, M. H., Senkal, C. E., . . . Spiegel, S. (2020). Targeting defective sphingosine kinase 1 in Niemann–Pick type C disease with an activator mitigates cholesterol accumulation. Web

Citación estilo Chicago

Newton, Jason, et al. Targeting Defective Sphingosine Kinase 1 in Niemann–Pick Type C Disease With an Activator Mitigates Cholesterol Accumulation. 2020.

Cita MLA

Newton, Jason, et al. Targeting Defective Sphingosine Kinase 1 in Niemann–Pick Type C Disease With an Activator Mitigates Cholesterol Accumulation. 2020.